X-Mozilla-Status: 0000
X-Mozilla-Status2: 00000000
X-Apparently-To: jeeproject@yahoo.com; Wed, 21 Oct 2015 19:22:01 +0000
Return-Path: <bounce-31110487_HTML-1027729945-50348584-10732224-144@bounce.exacttarget.com>
Received-SPF: pass (domain of bounce.exacttarget.com designates 207.67.38.42 as permitted sender)
X-YMailISG: Rv.Z1MMWLDvQ1s5UPwCUHkbG0TCUqEiY8dLoSKLbUqEpQXQx
 XMhyHNLPmGKrnmrwpcsFcqSimn5aNob.fuyjV8pJ.R.5pZi1LrO8850oKyOS
 _TMKGr_w34O8ZAT3wlua3RJX_tV9E0zfBlEQ0mdxDY02d8yERGXMcwLZYiKR
 oxqLzoG5_N1bZav1BQcqYPUr14Lr7ma7XpTvQbGIy.oKaN2mYohVL9ZE2FJi
 pQjqqqWdEdrTyaKe_X8htyfqZuGJYTrus4JLOXG5O_trsmyXOYWJFjRW2dpy
 bgIpgNc73fY8RhZlEPNpYBUGzHlUlvq_13howK4xifbAOatd11dr6XdSNgqM
 BZNGSjul8hvbU5dremlHzrt7AfhR07OQtfGMBXYpAXcKQx6qLjuwzS7Wsoe2
 hEooE3Bvza0K482OJM.xfM.twRWqCO1TeScj.hxRIvGFIi9mUrDNf8gi3Xrr
 6ASiz5KAIfOAf.kULhbpzM1EW5CyFIfDH.JuUntzj5fh6VsqLROVDbPrmwyt
 JdOfQXu0Tbjy_TOy5KlkXI6ok6QLUeiGeabp_5vtdFnjMqqV4x6d0HcsV6Wa
 f3eYPdy0nsXR5_rJ960zTF2NClMrZWmjJkJbDWBL4sNGl1TLTDEbr8JC4n93
 ..KiCA9eh5_a25pV2ELasOSSdXBDStsW5Q5coK2ZCcJ6lkzdTsk66UySDJqa
 D5HLl3Er.Gh9QPeux2zf9QVIdvCvKMOODtcSZ.tdP1Xh.mcY8nJL1KqdStOy
 OlESkuTdpFRXUyD.SmS2TZSeZQFUarJokhIkx5pfwVUdX6ahXQ_Is20jZmTh
 GL2xXbTx9TEd7Y5I2OBxFoUjMcG1y3tXOYnk9wPjN5JvDSIT_716JIiO03Rv
 3hV0PAG6PH9fiLf8vFX16IWmXlUw671b0w6t1IkHcCGG5pvTtv_xl9UkL2XB
 ubbQks6ci2NL6zpuz4DKrK.rMV2JLGOWOi3afbdq1QxZwEuzoZ4axR_m8r1J
 LagDrkEGy0fwoGq4JnJnA0XQPuGTwF7gkoU96TSLtebkPYSaxMT.TGKGdU07
 rcJEoaUtiFLNb8VbmrmcFalE37.XQM3wPNPYgGzWKkCRg0B86ghRexKuQ7Q8
 5wOFgClQMYb790y41dkIjZOXILxmtFq4whjocIv1posu81102xTW3q5oWUrc
 RRen6bCqb2tNiV3BslcXEP3Lxgx0RksMj.67LaO_camPxT7h6ZhmpzstRUZY
 z.3DVfUBMzHcpJ6NgcbtYeEboHzUUGwqt5QCeWI0GcT9x6QbmyKajxt7gDx_
 WoNLycGKEwofiH3g7dvGkDj2GP0Onb7niZw2SC8IFZc9AAYEZmV_uZiGdFL4
 AhJm5ODStn.hBley8mTSDx_UZIIhnlO9Qs7AP.mKPdke43ILgp6f2.6qH_Ii
 ICOainHZUorfhjkfOWc78cpTsdh6yaxuB3kalMsRF9Xx5wprPVVWBsB7Ugv9
 _OFMGdDVq9HnDCSPO6t91RyYi5XogxdN.JlUNR29PDGyWBp4B7f6vgHKwPvr
 m0sEsChzmAOJwlBc6TwtS1jNSIChj.O7akGcOZZlHsJjywKGR9vKk872oeQE
 UJdpCxumBQZuxn44MpbRk73bIew7OXKn9fwRE9WkPh4aZXfsvnG7xTK9FrjH
 czz4dG9jv.pErzO8qoOK0Ua8HwHr0ecAP7S9jg8KeXWHiU3ezJXwbKkR6CSb
 LHKJWxlm0JETYsIYK_kKHvC1tKzI2gwsYjRJZuGTE67SP4Af3Leyed16UHpW
 q24p5Euv.49KNvFtOYklmnEHVNgNbCDDEOhC0A--
X-Originating-IP: [207.67.38.42]
Authentication-Results: mta1569.mail.bf1.yahoo.com  from=23andme.com; domainkeys=neutral (no sig);  from=memberemail.com; dkim=pass (ok)
Received: from 127.0.0.1  (EHLO xtinmta06-42.exacttarget.com) (207.67.38.42)
  by mta1569.mail.bf1.yahoo.com with SMTP; Wed, 21 Oct 2015 19:22:01 +0000
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=20120116; d=memberemail.com;
 h=From:To:Subject:Date:MIME-Version:Message-ID:Content-Type;
 bh=GENq1B+F1ckRvqwhyIQbhSebyKw=;
 b=MVndfhU0fGITiUirkA/qOjTTyaMU+Cev9N2HKlouOZLsf6tGrEDPKRhlymqwUOnSj0q3EcoVwk+6
   OB2BTg4WhZCljh2v/6doWkiUrPaz392AGqrzkdLWH3woMbTwhxPLaYjDraVstV1+9kDvL8LfOrZP
   AFDEO4xnTCdFhoElE3M=
Received: by xtinmta06-42.exacttarget.com id h4viti163hsu for <jeeproject@yahoo.com>; Wed, 21 Oct 2015 13:17:08 -0600 (envelope-from <bounce-31110487_HTML-1027729945-50348584-10732224-144@bounce.exacttarget.com>)
From: "23andMe" <lists@23andme.com>
To: <jeeproject@yahoo.com>
Subject: CEO Update - Exciting News
Date: Wed, 21 Oct 2015 13:17:08 -0600
MIME-Version: 1.0
x-job: 10732224_50348584
Message-ID: <b8718d2d-a3a3-4d7b-a404-6dc3e7b93e6b@xtinmta199.xt.local>
Content-Type: multipart/alternative;
	boundary="WsAkXKItqb7G=_?:"
Content-Length: 13917

This is a multi-part message in MIME format.

--WsAkXKItqb7G=_?:
Content-Type: text/plain;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

x23andMeHaving trouble viewing this email? 
http://view.exacttarget.com/?j=fe5a117076600c787d10&m=fe6a15707267067f7710&ls=fde31d797561007b7112797d&l=fe661771746504797d13&s=fdf115707763037f7c1d7470&jb=ff66157471&ju= 
View it in your browser .

 
https://www.23andme.com/ 
 

   
 Dear Sam,
 


Today marks a great milestone in the history of personal genetics.I am thrilled to let you know that 23andMe is now the first and only genetic service available directly to you that includes reports that meet FDA standards.



 After nearly two years of work with the FDA, extensive user comprehension testing and a complete redesign, 23andMe is launching an entirely new experience that includes carrier status, wellness, trait and ancestry reports. We have also developed new and improved tools to share and compare your genetics with friends and family - and for those of you participating in research, we will provide new insights to explore.



As one of our earlier customers, you will continue to have access to your current health reports.The new experience will include redesigned versions of many of the same health and ancestry reports that you currently have.We have also added some new features and tools. 
 


Our team will be rolling out the new experience to you by early next year. We will send you an email when your account is updated. 



If you have any questions on the new experience, you can visit 
http://23andme.com/a/new_site_help/ 
our new FAQ page .Additionally, we have updated our 
https://www.23andme.com/about/privacy/ 
Privacy Statement  and 
https://www.23andme.com/about/tos/ 
Terms of Service  to support the new features, which I encourage you to read.



We are committed to bringing you a world class service which provides you with ongoing updates.The genetics revolution is here and we are excited to enable customers like you to keep learning about your DNA.Today is only the beginning!




Anne Wojcicki

CEO, 23andMe 

 

   
 Important Information on Carrier Status Tests: Our tests can be used to determine carrier status in adults, but cannot determine if you have two copies of the genetic variant. Each test is most relevant for people of certain ethnicities. The tests are not intended to diagnose a disease, or tell you anything about your risk for developing a disease in the future. On their own, carrier status tests are not intended to tell you anything about the health of your fetus, or your newborn child's risk of developing a particular disease later in life.


 
   

 
You are receiving this email because you are a member of 23andMe. 
Please add lists@23andme.com to your address book to ensure our emails reach your inbox. 




23andMe, Inc. uses the clinical laboratory services of 

National Genetics Institute, a subsidiary of Laboratory Corporation, 

2440 S Sepulveda Blvd., Ste #130, Los Angeles, CA 90064. 


(c) 2007-2015 23andMe, Inc. 899 W. Evelyn Avenue. Mountain View, CA 94041 

https://www.23andme.com/user/edit/notifications/ 
update your 23andMe email preferences |
http://cl.exct.net/unsub_center.aspx?s=fdf115707763037f7c1d7470&j=fe5a117076600c787d10&mid=fe6a15707267067f7710&lid=fe661771746504797d13&jb=ff66157471&ju= 
unsubscribe from 23andMe news and updates emails 
 
 





--WsAkXKItqb7G=_?:
Content-Type: text/html;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>x23andMe</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<meta name="viewport" content="width=device-width, initial-scale=1.0 " />
<meta name="format-detection" content="telephone=no" />
<style type="text/css">
body {
	margin: 0 !important;
	padding: 0 !important;
	-webkit-text-size-adjust: 100% !important;
	-ms-text-size-adjust: 100% !important;
	-webkit-font-smoothing: antialiased !important;
}
img {
	border: 0 !important;
	outline: none !important;
}
p {
	margin: 0px !important;
	padding: 0px !important;
}
table {
	border-collapse: collapse;
	mso-table-lspace: 0px;
	mso-table-rspace: 0px;
}
td, a, span {
	border-collapse: collapse;
	mso-line-height-rule: exactly;
}
.ExternalClass * {
	line-height: 100%;
}
</style>
</head>

<body>
<table width="100%" border="0" cellspacing="0" cellpadding="0" style="background-color:#c0c1c2;">
  <tbody>
    <tr>
      <td align="center"><table width="560" border="0" align="center" cellpadding="0" cellspacing="0" >
                            <!-- pre header-->
                      <tr>
                        <td height="50" align="center" bgcolor="#C0C1C2" class="em_grey" style="font-family:'Helvetica', Arial, sans-serif; font-size:14px; line-height:17px; color:#929292; font-style:normal;">Having trouble viewing this email? <a href="http://cl.exct.net/?qs=ecf2ac79e98e83097f0803ea90e8f4e152f20d996629ca359843d5a2fb05983bb6cf480d1b810812" target="_blank" style="text-decoration:underline; color:#929292;">View it in your browser</a>.</td>
                      </tr>
                      <!--// pre header--> 
          <tr>
            <td align="right" style="background-color:#ffffff;"><img src="http://image.exct.net/lib/fe6a15707267067f7710/m/1/batch1_introtoresearch_consented_1.jpg" width="387" height="56" alt="" style="display:block;" border="0" /></td>
          </tr>
          <tr>
            <td style="background-color:#ffffff;"><table width="100%" border="0" cellspacing="0" cellpadding="0">
              <tbody>
                <tr>
                  <td width="50">&nbsp;</td>
                  <td align="left"><a href="http://cl.exct.net/?qs=ecf2ac79e98e8309be1c30634aa660076d32c86371424ac2301fbedd0edb6b5a6573c7c92ef6a960" target="_blank"><img src="http://image.exct.net/lib/fe6a15707267067f7710/m/1/batch1_introtoresearch_consented_2.jpg" width="123" height="82" alt="23andMe" style="display:block;" border="0" /></a></td>
                  <td width="50">&nbsp;</td>
                </tr>
              </tbody>
            </table></td>
          </tr>
          <tr>
            <td align="center" valign="top" bgcolor="#ffffff" style="background-color:#ffffff;">
            <table width="100%" border="0" cellspacing="0" cellpadding="0" style="background-color:#ffffff;">
              <tbody>
                <tr>
                  <td>&nbsp;</td>
                  <td style="font-family:'Helvetica Neue', Helvetica, Arial, sans-serif; font-size:16px; line-height:28px; color:#707070;">&nbsp;</td>
                  <td>&nbsp;</td>
                </tr>
                <tr>
                  <td width="50">&nbsp;</td>
                  <td align="left" style="font-family:'Helvetica Neue', Helvetica, Arial, sans-serif; font-size:16px; line-height:28px; color:#707070; text-align:left;"><span style="font-family:'Helvetica Neue', Helvetica, Arial, sans-serif; font-size:16px; line-height:28px; color:#707070; text-align:left;">Dear Sam,
       <br />
                    <br />
                    Today marks a great milestone in the history of personal genetics.  I am thrilled to let you know that 23andMe is now the first and only genetic service available directly to you that includes reports that meet FDA standards.
                    <br />
                    <br />
                   After nearly two years of work with the FDA, extensive user comprehension testing and a complete redesign, 23andMe is launching an entirely new experience that includes carrier status, wellness, trait and ancestry reports. We have also developed new and improved tools to share and compare your genetics with friends and family - and for those of you participating in research, we will provide new insights to explore.  
                    <br />
                    <br />
As one of our earlier customers, you will continue to have access to your current health reports.  The new experience will include redesigned versions of many of the same health and ancestry reports that you currently have.  We have also added some new features and tools. 
 <br />
                    <br />
                  Our team will be rolling out the new experience to you by early next year. We will send you an email when your account is updated. 
<br />
                    <br />
If you have any questions on the new experience, you can visit <a href="http://cl.exct.net/?qs=ecf2ac79e98e8309762fbc7f3ee0c315d9e12e461d6b621316947851c5a3786f07aa0ff9e7b24fa2">our new FAQ page</a>.  Additionally, we have updated our <a href="http://cl.exct.net/?qs=ecf2ac79e98e83099b21ee69837be98733d187c0948a7d771539a117ef6637a0b3503bb393c9dc22">Privacy Statement</a> and <a href="http://cl.exct.net/?qs=ecf2ac79e98e8309924617c28c5d34eea803819200b2da02e734a69a90809e3d1292a174d582ed6b">Terms of Service</a> to support the new features, which I encourage you to read.
                    <br />
                    <br />
                    We are committed to bringing you a world class service which provides you with ongoing updates.  The genetics revolution is here and we are excited to enable customers like you to keep learning about your DNA.  Today is only the beginning!
                    
                    <br />
                    <br />
                    Anne Wojcicki<br />
                    CEO, 23andMe</span></td>
                  <td width="50">&nbsp;</td>
                </tr>
                </tbody>
            </table></td>
          </tr>
          <tr>
            <td height="40" style="background-color:#ffffff;">&nbsp;</td>
          </tr>
          <tr>
            <td width="560" height="10" valign="top" style="font-family:Arial, sans-serif; font-size:10px; line-height:10px; mso-line-height-rule:exactly;"><img src="http://image.exct.net/lib/fe6a15707267067f7710/m/1/Footer_Green+Stripe.jpg" width="560" height="10" alt="" style="display:block;" border="0"/></td>
          </tr>
          <tr>
            <td align="center" valign="top" bgcolor="#f7f9fa"><table width="100%" border="0" cellspacing="0" cellpadding="0">
              <tbody>
                <tr>
                  <td>&nbsp;</td>
                  <td style="font-family:'Helvetica Neue', Helvetica, Arial, sans-serif; font-size:16px; line-height:28px; color:#707070;">&nbsp;</td>
                  <td>&nbsp;</td>
                </tr>
                <tr>
                  <td width="50">&nbsp;</td>
                  
<td align="left" style="font-family:'Helvetica Neue', Helvetica, Arial, sans-serif; font-size:11px; line-height:16px; color:#333435; text-align:left; font-style:italic;">Important Information on Carrier Status Tests: Our tests can be used to determine carrier status in adults, but cannot determine if you have two copies of the genetic variant. Each test is most relevant for people of certain ethnicities. The tests are not intended to diagnose a disease, or tell you anything about your risk for developing a disease in the future. On their own, carrier status tests are not intended to tell you anything about the health of your fetus, or your newborn child's risk of developing a particular
 disease later in life.
                    <br />
                    <br /></td>
                  <td width="50">&nbsp;</td>
                </tr>
                <tr>
                  <td style="font-family:'Helvetica Neue', Helvetica, Arial, sans-serif; font-size:16px; line-height:28px; color:#707070;">&nbsp;</td>
                  <td align="left" style="font-family:'Helvetica Neue', Helvetica, Arial, sans-serif; font-size:11px; line-height:16px; color:#9c9ea1; text-align:left; font-style:italic;">&nbsp;</td>
                  <td>&nbsp;</td>
                </tr>
                </tbody>
            </table></td>
          </tr>
          <tr>
            <td height="30" bgcolor="#C0C1C2">&nbsp;</td>
          </tr>
          <tr>
            <td bgcolor="#C0C1C2" align="center" style="font-family:Arial, Helvetica, sans-serif; font-size:11px; mso-line-height-rule:exactly; text-align:center; line-height:18px; color:#333435;" class="dividerHeader">You are receiving this email because you are a member of 23andMe. <br />Please add <span style="color:#6b6b6b;">lists@23andme.com</span> to your address book to ensure our emails reach your inbox. 

                  <br />
                  <br />
                  23andMe, Inc. uses the clinical laboratory services of <br />
                  National Genetics Institute, a subsidiary of Laboratory Corporation, <br />
                  2440 S Sepulveda Blvd., Ste #130, Los Angeles, CA 90064. <br />
                  <br />
                  &copy; 2007-2015 23andMe, Inc. 899 W. Evelyn Avenue. Mountain View, CA 94041 <br />
                  <a href="http://cl.exct.net/?qs=ecf2ac79e98e83093bc31622d2d545c33c4180426b8933b009e36feba39cecbeab4cffca143fc100" style="color:#929292; text-decoration:none;">update your 23andMe email preferences</a> <span style="color:#929292; text-decoration:none;">|</span> <a href="http://cl.exct.net/?qs=ecf2ac79e98e830938fdf17cad0bc24fef0eb7eda56420c9378268a75f8813519c5c2cb5868fba27" style="color:#929292; text-decoration:none;">unsubscribe from 23andMe news and updates emails</a></td>
          </tr>
          <tr>
            <td height="50" bgcolor="#C0C1C2">&nbsp;</td>
          </tr>
          <tr>
            <td bgcolor="#C0C1C2">&nbsp;</td>
          </tr>
      
      </table></td>
    </tr>
  </tbody>
</table>
<img src="http://cl.exct.net/open.aspx?ffcb10-fe5a117076600c787d10-fde31d797561007b7112797d-fe6a15707267067f7710-fe661771746504797d13-fdf115707763037f7c1d7470-ff66157471" width="1" height="1">
</body>
</html>

--WsAkXKItqb7G=_?:--


